Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled time : 15:00 save search
Jazz Pharmaceuticals to Present Long-Term and Real-World Data Emphasizing Commitment to Treatment-Resistant Epilepsy at the 2023 American Epilepsy Society Annual Meeting
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
JAZZ | $119.11 0.74% 0.0% 640K
|
Health Technology
|
| O: -0.66%
H: 0.0%
C: 0.0%
pharmaceuticals meeting
GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
WGS | $1.8 2.86% 2.78% 280K
|
Professional, Scientific, and T...
|
| O: -0.57%
H: 0.0%
C: 0.0%
meeting
Intensity Therapeutics Selected for Spotlight Oral Presentation at the 2023 San Antonio Breast Cancer Symposium
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
INTS | $3.15 28.55% 17.35% 22K
|
|
| O: 8.61%
H: 0.0%
C: 0.0%
breast symposium presentation cancer therapeutics
Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
OVID | $3.195 7.4% 7.03% 110K
|
Health Technology
|
| O: 3.53%
H: 0.0%
C: 0.0%
meeting therapeutics
Palvella Therapeutics and Ligand Pharmaceuticals Expand Strategic Partnership to Accelerate Phase 3 Development of QTORIN™ rapamycin for Microcystic Lymphatic Malformations and Additional High Unmet Need Clinical Indications
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
LGND | $58.75 0.76% 2.3% 74K
|
Health Technology
|
| O: 0.36%
H: 0.0%
C: 0.0%
partnership pharmaceuticals therapeutics
Allogene Therapeutics Announces Participation in December Investor Conference
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
ALLO | $2.52 7.23% 0.0% 2.4M
|
Health Technology
|
| O: 3.95%
H: 0.0%
C: 0.0%
conference therapeutics
Neurona Therapeutics Presents New Clinical Data from First Cohort in Ongoing Phase I/II Open-Label Trial of NRTX-1001 Cell Therapy for Drug-resistant Mesial Temporal Lobe Epilepsy (MTLE)
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
TOT | $48.3 0%
|
Energy Minerals
| Email alert
Add to watchlist
nrtx-1001 cell ongoing trial therapeutics therapy
MUSIC BIZ WORLDWIDE: ‘SPINNIN’ RECORDS HAS AN INDEPENDENT APPROACH, BUT WITH MAJOR OPPORTUNITIES ON BOTH A LOCAL AND WORLDWIDE LEVEL.
Published: 2023-12-01 (Crawled : 15:00) - wmg.com
FNCTF | $12.36 0.08% -26.03% 1K
|
Communications
| Email alert
Add to watchlist
worldwide
300 PUBLISHING SIGNEE SEAN MOMBERGER SCORES BILLBOARD HOT 100 NO. 1 WITH JACK HARLOW’S “LOVIN ON ME”
Published: 2023-12-01 (Crawled : 15:00) - wmg.com
FNCTF | $12.36 0.08% -26.03% 1K
|
Communications
| Email alert
Add to watchlist
jack 100 hot
VARIETY: YNG LVCAS, PESO PLUMA AND MORE TALK EVOLUTION OF ‘LA BEBE’: ‘COULDN’T HAVE COME AT A BETTER TIME
Published: 2023-12-01 (Crawled : 15:00) - wmg.com
FNCTF | $12.36 0.08% -26.03% 1K
|
Communications
| Email alert
Add to watchlist
NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
NPCE S | $8.9 -1.0% -1.35% 30K
|
Manufacturing
|
| O: 0.51%
H: 0.0%
C: 0.0%
system meeting
Gain Therapeutics Announces Preclinical Data Showing Restoration of Enzymatic Function with Novel Allosteric Regulators in GM1 Gangliosidosis Model
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
GANX | $2.2 2.8% 10.32% 53K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
preclinical therapeutics
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
NAVB | $0.0699 39.52% -43.49% 680K
|
Health Technology
| Email alert
Add to watchlist
royalty agreement
Cyclacel Regains Compliance With Nasdaq Listing Rule Following Filing of Its Form 10-Q With the SEC
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
CYCC | $0.2699 -10.03% 6.11% 450K
|
Health Technology
|
| O: 11.87%
H: 19.9%
C: -10.07%
nasdaq
Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
SNYNF | $94.0 1.34% 1.34% 860
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
TEVA | $9.71 -1.12% 0.0% 6.2M
|
Health Technology
|
| O: -0.52%
H: 3.73%
C: 1.87%
SNY | $46.72 -0.06% -0.06% 1.1M
|
Health Technology
|
| O: -1.09%
H: 0.0%
C: 0.0%
disease treatment collaboration teva deal
Protara Therapeutics Announces Presentation of Additional Encouraging Data from Phase 1a ADVANCED-1 Trial of TARA-002 in NMIBC at the 24th Annual Meeting of the Society of Urologic Oncology
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
TARA | $1.435 -1.03% -1.05% 20K
|
Health Technology
|
| O: -2.01%
H: 4.71%
C: -0.68%
tara-002 presentation meeting trial therapeutics
Guardant Health to present data at San Antonio Breast Cancer Symposium demonstrating utility of liquid biopsy in biomarker identification, therapy selection and residual disease detection
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
GH | $26.33 4.61% 0.61% 1.1M
|
Health Services
|
| O: 1.51%
H: 3.92%
C: -1.29%
disease breast health symposium biomarker cancer therapy
urban-gro, Inc. Awarded $9.6 Million Industrial Design-Build Contract with Existing CPG Client
Published: 2023-11-30 (Crawled : 15:00) - globenewswire.com
UGRO | $1.18 4.43% -2.26% 97K
|
|
| O: 5.17%
H: 1.64%
C: -7.38%
contract
Gilead’s Leadership in Metastatic Breast Cancer Showcased With New Trodelvy Data at San Antonio Breast Cancer Symposium 2023
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
GILD | $77.65 1.37% -0.05% 5.4M
|
Health Technology
|
| O: 0.2%
H: 1.8%
C: 1.62%
trodelvy breast symposium cancer
Ocuphire Pharma Announces Presentation at Ophthalmology Innovation Summit (OIS) XIIIInvestor Call with CEO, George Magrath, M.D., M.B.A., M.S. on December 5, 2023
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
OCUP A | $2.99 -1.97% -2.18% 290K
|
Health Technology
|
| O: 3.28%
H: 8.48%
C: 7.77%
pharma presentation innovation
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
ID 4 | $0.077 -9.41% 25.97% 420K
|
Finance
BKKT 4 | $1.88 25.33% 14.89% 4.8M
|
MGLD | $1.03 7.77% 14K
|
Manufacturing
CZOO | $0.4316 -6.52% 6.7% 65K
|
SATX | $0.4226 -1.72% 6.48% 29K
|
n/a
CCJ | $45.4 -1.13% 4.6% 3.9M
|
Non-Energy Minerals
AUMN | $0.562 0.34% 4.5% 360K
|
Non-Energy Minerals
ERJ | $18.69 6.86% 4.33% 2.9M
|
Electronic Technology
JBL | $116.91 1.38% 4.3% 2M
|
Electronic Technology
SAIC 4 | $119.92 2.14% 4.24% 460K
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.